CX NEWS
CX 2025: Aortic Programme Highlights
Dittmar Böckler (Heidelberg, Germany) CX Co-Chair and member of the Aortic Executive Board offers an exclusive preview of the highlights in the latest CX Aortic Challenges update, and explores what makes the CX symposium a unique experience. [...]
CX 2025: Venous & Lymphatic Programme Highlights
Stephen Black (London, United Kingdom), a member of the Venous & Lymphatic Executive Board, discusses the evolution of the venous programme, key workshop activities, and must-attend sessions in the upcoming CX Venous & [...]
Charing Cross: A “Must-Attend” for Vascular Specialists
Eric Secemsky, Director of Vascular Intervention at Beth Israel Deaconess Medical Center (Boston, United States), joined us at PVI 2024 to explain why the Charing Cross Symposium is a "must-attend" event for vascular specialists. [...]
CX 2025: Vascular Access & Renal Interventions Programme Highlights
 Kate Steiner (Stevenage, United Kingdom) and Nicholas Inston (Birmingham, United Kingdom) members of the Vascular Access & Renal Interventions Executive Board highlight their key sessions coming in the CX Vascular Access Challenges [...]
CX 2025: Peripheral Arterial Programme Highlights
 Andrew Holden (Auckland, New Zealand) CX Co-Chair and member of the Peripheral Arterial Executive Board highlights top sessions that he's looking forward to in the CX Peripheral Arterial Challenges update. The peripheral [...]
CX 2025: NEW Challenging Cases and Complications Competition
In this interview, CX Co-Chair Andrew Holden (Auckland, New Zealand) discusses the new Challenging Cases and Complications Competition at CX 2025. This year, we’re inviting trainees and young doctors to submit their toughest [...]